Skip to main content

AAV5-PAH Gene Therapy Clinical Study for Subjects With Phenylketonuria: Update

Clinical Stage and Regulatory Timeline

BMN-307 is an investigational gene transfer therapy intended to deliver its phenylalanine hydroxylase (PAH) gene to the liver tissue for the production of PAH enzyme protein. Biomarin is conducting a Phase 1/2 clinical trial (PHEARLESS) to evaluate the safety and efficacy of AAV-PAH gene therapy in subjects with PKU. On September 2020, Biomarin announced the dosing of the first patients in their clinical studies.

Viral Vector and Gene Construct: 

AAV5.-Liver-specific promoter- PAH. The PAH gene under the liver tissue-specific promoter that drives the expression in the liver tissue. AAV5 is an adeno-associated virus that has been previously used to deliver the gene into liver tissue and successful transgene expression. 

Clinical Phase:

Biomarin is currently conducting a Phase 1/2 (NCT04480567) open-label, dose-escalation study to evaluate the safety and efficacy of BMN307 in PKU subjects with PAH deficiency. The proposed sample size is 100 PKU subject with PAH deficiency for the study.

Outcome Measures

Primary Outcome Measure

  • Change from baseline in mean Plasma Phe levels

Secondary Outcome

  • Change from baseline in mean Plasma Phe levels
  • Change from baseline in dietary protein intake from intact food
  • Number of participants with treatment-emergent adverse event

Key Results from Phase 1/2a 
First Patient Dosed in September 2020

Efficacy 
Not available 

Durability:

Not available

Safety: Not available

Serious Adverse Events: N/A

Immunogenicity

Antibody Response:N/A

T cell Response (ELISpot): N/A

Non-Clinical  Data Based on 2019 RDDay Presentation

It was reported that AAV5-PAH administration resulted in lifetime correction of Phe level similar to wildtype in the Enu-2(pah knockout) mice and supported the clinical development of BMN 307 program (RDDay2019 Presentation). 

Reference

Clinicaltrial.gov

Biomarin Press Release



Comments

Popular posts from this blog

Carbohydrate Metabolism: MCQs and answers on Glycolysis & Gluconeogenesis

                                      MCQ on Glycolysis & Gluconeogenesis 1) Which of the following enzyme is not involved in galactose metabolism? a) Glucokinase b) Galactokinase c) Galactose-1-Phosphate Uridyl transferase d) UDP-Galactose 4- epimerase 2) Which of the following enzyme is defective in galactosemia (type I) - a fatal genetic disorder in infants? a) Glucokinase b) Galactokinase c) Galactose-1-Phosphate Uridyl transferase d) UDP-Galactose 4- epimerase 3) In the liver, the accumulation of which of the following metabolite attenuates the inhibitory of ATP on phosphofructokinase? a) Glucose-6-Phosphate b) Citrate c) Fructose-1,6-Bisphosphate d) Fructose-2,6-Bisphosphate 4) Mutation in which of the following enzymes leads to a glycogen storage disease known as "Tarui’s disease"? a) Glucokinase b) Phosphofructokinase c) Phosphoglucomutase d) Pyruvate Kinase 5) E...

MCQs and Answers on cultivation (culture/incubation), Isolation and Identification of microorganisms: Medical Microbiology

40 plus questions - Multiple Choice Questions on Classification, Culture, and Identification of the microorganisms 1. Which of the following microorganism has the cocci cell shapes and sizes arranged usually in tetrad structures? a)  Streptococcus pneumoniae b)  Staphylococcus aureus c)  Chlamydia trachomatis d)  Neisseria meningitidis 2. What are the different growth morphology and cell structures used for the classification of fungi? Select all the correct answers: a) Yeast b) Mold c) Mycelia d) Protozoa 3. Which of the following media is formulated with additional nutrients to support the growth of fastidious or nutritionally demanding bacteria that may not grow well on basic media? a) Differential media b) Enriched media c) Nutrient agar (media) d) Selective media 4. Which of the following metabolic characteristic is a distinguishing characteristic and identification of colonies of  E. coli ? a) Hydrogen sulfide formation b) Indole Formation c) Lactose fe...

Multiple Choice Questions (MCQs) on Diabetes Mellitus: Pathogenesis, Diagnosis and Treatment

                                        MCQs on Diabetes mellitus 1) Diabetes mellitus is a disorder characterized by hyperglycemia.  Which of the following is not the common characteristic features of type 2 diabetes mellitus ? a) Impaired insulin secretion b) Increased Insulin resistance  c) Diabetic ketoacidosis d) Excessive hepatic glucose production 2) Which of the following are the characteristic features of type 1 diabetes mellitus? a) Type 1 diabetes is caused by an absolute deficiency of insulin. b) Type 1 diabetes is associated with the autoimmune destruction of beta cells.  c) Patients with  uncontrolled type 1 diabetes present with diabetic ketoacidosis d) All of the above   3) Which of the following serum measurements are not used for the diagnosis of diabetes mellitus? a) Fasting blood glucose d) Postprandial blood glucose  c) Insulin ...